Glipizide Tablet, Extended Release
Product Images NDC 60760-793

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Glipizide (NDC 60760-793). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by St. Mary's Medical Park Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

G (Glipizide 60760 793 90)

Label for Glipizide Extended-Release Tablets 10 mg in a 90 count package by St. Mary's Medical Park Pharmacy. The label shows the proprietary and generic name, dosage strength, form, quantity, and manufacturer details. It includes storage instructions and barcode information. The label notes the manufacturer as Aurobindo Pharma USA, Inc. with packaging by St. Mary's in Oro Valley, AZ.*

FDA Label Image

Chemical Structure (Glipizide Str)

Chemical structure of Glipizide, illustrating its molecular framework with labeled functional groups and ring structures characteristic of this active ingredient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.